Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Predicting motor, cognitive & functional impairment in Parkinson's.

Lo C, Arora S, Baig F, Lawton MA, El Mouden C, Barber TR, Ruffmann C, Klein JC, Brown P, Ben-Shlomo Y, de Vos M, Hu MT.

Ann Clin Transl Neurol. 2019 Aug;6(8):1498-1509. doi: 10.1002/acn3.50853. Epub 2019 Jul 26.

2.

Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity.

Baig F, Kelly MJ, Lawton MA, Ruffmann C, Rolinski M, Klein JC, Barber T, Lo C, Ben-Shlomo Y, Okai D, Hu MT.

Neurology. 2019 Aug 13;93(7):e675-e687. doi: 10.1212/WNL.0000000000007942. Epub 2019 Jul 16.

PMID:
31311842
3.

Predictors of motor complications in early Parkinson's disease: A prospective cohort study.

Kelly MJ, Lawton MA, Baig F, Ruffmann C, Barber TR, Lo C, Klein JC, Ben-Shlomo Y, Hu MT.

Mov Disord. 2019 Aug;34(8):1174-1183. doi: 10.1002/mds.27783. Epub 2019 Jul 8.

PMID:
31283854
4.

Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells.

Smith AM, Depp C, Ryan BJ, Johnston GI, Alegre-Abarrategui J, Evetts S, Rolinski M, Baig F, Ruffmann C, Simon AK, Hu MTM, Wade-Martins R.

Mov Disord. 2018 Oct;33(10):1580-1590. doi: 10.1002/mds.104. Epub 2018 Oct 7.

5.

Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD.

Arora S, Baig F, Lo C, Barber TR, Lawton MA, Zhan A, Rolinski M, Ruffmann C, Klein JC, Rumbold J, Louvel A, Zaiwalla Z, Lennox G, Quinnell T, Dennis G, Wade-Martins R, Ben-Shlomo Y, Little MA, Hu MT.

Neurology. 2018 Oct 16;91(16):e1528-e1538. doi: 10.1212/WNL.0000000000006366. Epub 2018 Sep 19.

6.

Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.

Ruffmann C, Bengoa-Vergniory N, Poggiolini I, Ritchie D, Hu MT, Alegre-Abarrategui J, Parkkinen L.

Neuropathol Appl Neurobiol. 2018 Dec;44(7):722-736. doi: 10.1111/nan.12486. Epub 2018 May 8.

7.

Cortical structural involvement and cognitive dysfunction in early Parkinson's disease.

Klein JC, Rolinski M, Griffanti L, Szewczyk-Krolikowski K, Baig F, Ruffmann C, Groves AR, Menke RAL, Hu MT, Mackay C.

NMR Biomed. 2018 Apr;31(4):e3900. doi: 10.1002/nbm.3900. Epub 2018 Feb 13.

PMID:
29436039
8.

Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.

Barber TR, Lawton M, Rolinski M, Evetts S, Baig F, Ruffmann C, Gornall A, Klein JC, Lo C, Dennis G, Bandmann O, Quinnell T, Zaiwalla Z, Ben-Shlomo Y, Hu MTM.

Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx071.

9.

Personality and addictive behaviours in early Parkinson's disease and REM sleep behaviour disorder.

Baig F, Lawton MA, Rolinski M, Ruffmann C, Klein JC, Nithi K, Okai D, Ben-Shlomo Y, Hu MT.

Parkinsonism Relat Disord. 2017 Apr;37:72-78. doi: 10.1016/j.parkreldis.2017.01.017. Epub 2017 Feb 1.

10.

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies.

Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MT, Parkkinen L, Green AJ.

Ann Clin Transl Neurol. 2016 Aug 28;3(10):812-818. eCollection 2016 Oct.

11.

Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease.

Lawton M, Hu MT, Baig F, Ruffmann C, Barron E, Swallow DM, Malek N, Grosset KA, Bajaj N, Barker RA, Williams N, Burn DJ, Foltynie T, Morris HR, Wood NW, May MT, Grosset DG, Ben-Shlomo Y.

Parkinsonism Relat Disord. 2016 Dec;33:96-101. doi: 10.1016/j.parkreldis.2016.09.023. Epub 2016 Sep 25.

12.

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.

Swallow DM, Lawton MA, Grosset KA, Malek N, Klein J, Baig F, Ruffmann C, Bajaj NP, Barker RA, Ben-Shlomo Y, Burn DJ, Foltynie T, Morris HR, Williams N, Wood NW, Hu MT, Grosset DG.

J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1183-1190. doi: 10.1136/jnnp-2016-313642. Epub 2016 Sep 26.

13.

Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?

Ruffmann C, Parkkinen L.

Mov Disord. 2016 Feb;31(2):193-202. doi: 10.1002/mds.26480. Epub 2016 Jan 22. Review.

14.

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.

Ruffmann C, Calboli FC, Bravi I, Gveric D, Curry LK, de Smith A, Pavlou S, Buxton JL, Blakemore AI, Takousis P, Molloy S, Piccini P, Dexter DT, Roncaroli F, Gentleman SM, Middleton LT.

Neuropathol Appl Neurobiol. 2016 Aug;42(5):436-50. doi: 10.1111/nan.12294. Epub 2015 Dec 2.

15.

Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study.

Gallo V, Brayne C, Forsgren L, Barker RA, Petersson J, Hansson O, Lindqvist D, Ruffmann C, Ishihara L, Luben R, Arriola L, Bergareche A, Gavrila D, Erro ME, Vanacore N, Sacerdote C, Bueno-de-Mesquita B, Vermeulen R, Seelen M, Sieri S, Masala G, Ramat S, Kyrozis A, Thricopolou A, Panico S, Mattiello A, Kaaks R, Teucher B, Katzke V, Kloss M, Curry L, Calboli F, Riboli E, Vineis P, Middleton L.

Neurodegener Dis. 2015;15(6):331-8. doi: 10.1159/000381857. Epub 2015 Sep 17.

PMID:
26375921
16.

Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease.

Ruffmann C, Parkkinen L.

Neurology. 2015 Sep 1;85(9):834. doi: 10.1212/WNL.0000000000001904. No abstract available.

PMID:
26324865
17.

Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives.

Baig F, Lawton M, Rolinski M, Ruffmann C, Nithi K, Evetts SG, Fernandes HR, Ben-Shlomo Y, Hu MT.

Mov Disord. 2015 Nov;30(13):1759-66. doi: 10.1002/mds.26281. Epub 2015 Jul 14.

18.

Parkinson's disease beyond 20 years.

Cilia R, Cereda E, Klersy C, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Ruffmann C, Isaias IU, Goldwurm S, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):849-55. doi: 10.1136/jnnp-2014-308786. Epub 2014 Oct 3.

PMID:
25280915
19.

Later age at onset in Parkinson's disease over twenty years in an Italian tertiary clinic.

Pezzoli G, Klersy C, Cilia R, Canesi M, Zecchinelli AL, Mariani CB, Tesei S, Sacilotto G, Meucci N, Zini M, Isaias IU, Ruffmann C, Barichella M, Cassani E, Goldwurm S, Cereda E.

Parkinsonism Relat Disord. 2014 Nov;20(11):1181-5. doi: 10.1016/j.parkreldis.2014.08.017. Epub 2014 Sep 3.

PMID:
25219972
20.

Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome.

Cilia R, Siri C, Canesi M, Zecchinelli AL, De Gaspari D, Natuzzi F, Tesei S, Meucci N, Mariani CB, Sacilotto G, Zini M, Ruffmann C, Pezzoli G.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):311-8. doi: 10.1136/jnnp-2012-303988. Epub 2013 Apr 16.

PMID:
23591553
21.

Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients.

Tremolizzo L, Difrancesco JC, Rodriguez-Menendez V, Riva C, Conti E, Galimberti G, Ruffmann C, Ferrarese C.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):47-51. doi: 10.1016/j.pnpbp.2012.04.016. Epub 2012 May 11.

PMID:
22584634
22.

Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2).

Ruffmann C, Zini M, Goldwurm S, Bramerio M, Spinello S, Rusconi D, Gambacorta M, Tagliavini F, Pezzoli G, Giaccone G.

Acta Neuropathol. 2012 Jun;123(6):901-3. doi: 10.1007/s00401-012-0991-7. Epub 2012 May 4. No abstract available.

PMID:
22555654
23.

Atypical tauopathy in a patient with LRRK2-G2019S mutation and tremor-dominant Parkinsonism.

Ruffmann C, Giaccone G, Canesi M, Bramerio M, Goldwurm S, Gambacorta M, Rossi G, Tagliavini F, Pezzoli G.

Neuropathol Appl Neurobiol. 2012 Jun;38(4):382-6. doi: 10.1111/j.1365-2990.2011.01216.x. No abstract available.

PMID:
21883375
24.

Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report.

DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, Galimberti G, Conti E, Curtò NA, Marzorati L, Remida P, Tagliavini F, Savoiardo M, Ferrarese C.

Neurology. 2011 Mar 1;76(9):842-4. doi: 10.1212/WNL.0b013e31820e773c. No abstract available.

PMID:
21357837
25.

Parkin analysis in early onset Parkinson's disease.

Sironi F, Primignani P, Zini M, Tunesi S, Ruffmann C, Ricca S, Brambilla T, Antonini A, Tesei S, Canesi M, Zecchinelli A, Mariani C, Meucci N, Sacilotto G, Cilia R, Isaias IU, Garavaglia B, Ghezzi D, Travi M, Decarli A, Coviello DA, Pezzoli G, Goldwurm S.

Parkinsonism Relat Disord. 2008;14(4):326-33. doi: 10.1016/j.parkreldis.2007.10.003. Epub 2007 Nov 19.

PMID:
18519021
26.

Third cranial nerve palsy? Look for a sicca syndrome.

Galbussera A, Tremolizzo L, Tagliabue E, Ceresa C, Cilia R, Ruffmann C, Ferrarese C, Appollonio I.

J Neurol Sci. 2007 Feb 15;253(1-2):88-9. Epub 2007 Jan 10.

PMID:
17217966
27.

Epileptogenic drugs: a systematic review.

Ruffmann C, Bogliun G, Beghi E.

Expert Rev Neurother. 2006 Apr;6(4):575-89. Review.

PMID:
16623656

Supplemental Content

Loading ...
Support Center